MedTrace Logo

Measurement of in Vivo Mitochondrial Capacity in Infants

NCT03976596 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2026-02-03

No results posted yet for this study

Summary

The overarching aim of this project is to determine the test re-test reliability of 31P-magnetic resonance spectroscopy measurements in infants. Primary endpoints include two separate measures of in vivo mitochondrial capacity (ATPmax) over a 1-10 day period to assess feasibility and reliability.

Conditions

  • Healthy Infants

Sponsors & Collaborators

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Leanne M Redman, PhD · Pennington Biomedical Research Center

Eligibility

Min Age
14 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-21
Primary Completion
2019-07-02
Completion
2019-07-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03976596 on ClinicalTrials.gov